Pembrolizumab has durable effect in previously treated MSI-H/dMMR advanced endometrial cancer Presented ByProf. David O’Malley, Ohio State University, USA TrialPhase 2, KEYNOTE-158 ConferenceESMO 2021 19 November, 2021 09:23
